US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 4, 2020 (6 years ago)

Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Stability Specifications: Below specification result for buprenorphine release rate.

What was recalled

Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva Pharmaceuticals USA Inc., North Wales, PA 19454, carton NDC: 0093-3656-40, patch NDC: 0093-3656-21.

Recalling firm
Teva Pharmaceuticals USA
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0003-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Buprenorphine recalls

See all